Advance Directives Uncommon in Patients with Recurrent Hematologic Cancers

Elsevier Global Medical News. 2009 Oct 1, R Finn

SAN FRANCISCO (EGMN) - Only a small minority of patients with relapsed leukemia or lymphoma discussed advance directives with their physicians, according to a survey of 75 such patients at Virginia Commonwealth University in Richmond.Although 35 (47%) of the patients had an advance directive, just 5 (7%) had ever discussed advance directives with their oncologist, said Dr. Thomas J. Smith at the annual Oncology Congress presented by Reed Medical Education."You would think that most of them would've...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Meet Our Experts

Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.

Editors' Choice

Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration